New AntiVirals 

for Infections 

with Pandemic 

Potential

For infectious disease management and control, vaccines are considered golden countermeasures 
but are not the most adequate tool for mitigating 
the early effects of an outbreak.

Taking the recent COVID-19 pandemic as an example, access to broadly applicable therapeutic antivirals would have had a major impact, decreasing the human toll of the disease, and alleviating the burden carried by health care systems. It is urgent to focus resources and efforts on the development of broad spectrum antiviral drugs against unknown pathogens.

The New AntiVirals for Infections with Pandemic Potential (NAVIPP) consortium aims to strengthen the EU’s readiness and response capacity to viral threats by assembling an international R&D platform for antiviral drug development against pandemic prone pathogens.

navipp by
numbers

0

partners

0

countries

0

years EU-funded
project

0

millions €

NEWS

  • Nipah Virus: Understanding the Threat, Exploring New Solutions

    NAVIPP Scientific Watch Serie A deadly virus Nipah virus is one of the deadliest pathogens known, with mortality rates up to 75%. It has caused repeated outbreaks in South Asia, raising global concern due to its potential for person-to-person transmission. What recent research shows New studies suggest that aerosol transmission, while rare, may play a…

  • Urban Wildlife, Hidden Pathogens: A Wake-Up Call from Mali

    NAVIPP Scientific Watch Serie Pathogens in the city A recent study in Bamako, Mali, investigated rodents and shrews living in the city. Researchers discovered pathogens of public health concern, including Bartonella species, Coxiella burnetii (the agent of Q fever), and Trypanosoma. Although prevalence was low, these findings underscore the importance of monitoring urban wildlife. Why…

  • Ebola’s Hidden History: What Viral Evolution Teaches Us

    NAVIPP Scientific Watch Serie A virus with a complex past Ebola virus (EBOV) has caused multiple deadly outbreaks since the 1970s. For a long time, scientists believed these events traced back to a narrow genetic bottleneck. But new research is rewriting this story. New insights from phylogeny Recent analyses suggest that Ebola’s origins may stretch…